News

Results from the trial published in the New England Journal of Medicine demonstrated that two doses of the rotavirus vaccine candidate given two months apart at two and

The plaintiffs allege that the advertising for the GSK / Roche product misleads consumers and physicians about the benefits of the drug, specifically that the advertising for Boniva

States that have seen a particularly high increase in flu incidence recently include California, Arizona, New Mexico, Utah, Texas, Oregon, Nevada and Kansas. Under the company’s plan, Tamiflu

The research could open up pathways for the development of treatments for multiple sclerosis (MS) and other such neuro-inflammatory disorders. The researchers reported experiments showing how the endocannabinoid

Roche and Xencor entered into the initial collaboration in January 2005, in which Roche applies Xencor’s XmAb Fc domains with the aim of enhancing the therapeutic efficacy of

The study compares Natrecor with placebo in order to gauge the risk profile of the drug. The new findings may exacerbate recent safety concerns around the drug, which

This follows a similar approval for a phase I/II trial for ZIO-201 in patients with advanced sarcoma. Patient treatment in both trials is expected to start in early

Under the terms of the agreement, Pfizer will fund further research at Sangamo and Sangamo will use its zinc finger DNA-binding protein (ZFP) technology to develop additional cell

The approval means that Climara Pro is the only combination once-a-week hormone therapy patch approved for the prevention of postmenopausal osteoporosis and the relief of vasomotor symptoms associated